Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 33

Results For "ASH"

2930 News Found

Antara Senior Care launches second Chennai care home amid growing senior population
News | February 10, 2026

Antara Senior Care launches second Chennai care home amid growing senior population

The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity


Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
Supply Chain | February 10, 2026

Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics

Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions


Zydus Lifesciences reports strong Q3 & 9M FY26 growth
News | February 10, 2026

Zydus Lifesciences reports strong Q3 & 9M FY26 growth

Revenue from operations surged 30% year-on-year to Rs. 68,645 million


Time Medical India unveils next-generation MRI platforms at IRIA 2026
News | February 10, 2026

Time Medical India unveils next-generation MRI platforms at IRIA 2026

The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology


SMS Pharmaceuticals posts strong Q3 with 29% PAT growth, full-year targets on track
News | February 10, 2026

SMS Pharmaceuticals posts strong Q3 with 29% PAT growth, full-year targets on track

The company’s EBITDA margin remained resilient above 20%


DKSH Malaysia teams up with Pfizer to boost access to anti-infective therapies
News | February 09, 2026

DKSH Malaysia teams up with Pfizer to boost access to anti-infective therapies

Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments


MHRA warns of extremely rare vision risk linked to semaglutide
Healthcare | February 09, 2026

MHRA warns of extremely rare vision risk linked to semaglutide

Semaglutide—a glucagon?like peptide?1 receptor agonist (GLP-1RA) sold as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management and cardiovascular risk reduction


Bayer’s asundexian demonstrated 26% reduction in stroke after a non-cardioembolic ischemic stroke
Clinical Trials | February 07, 2026

Bayer’s asundexian demonstrated 26% reduction in stroke after a non-cardioembolic ischemic stroke

These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke


FUJIFILM India unveils four new imaging & healthcare IT solutions at IRIA 2026
News | February 07, 2026

FUJIFILM India unveils four new imaging & healthcare IT solutions at IRIA 2026

Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy